PEAK PROCESSING LIMITED — Regulatory Filings 2020

Nov 2, 2020

==> picture [595 x 148] intentionally omitted <==

ASX Announcement | 2 November 2020 Althea Group Holdings (ASX:AGH)

Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (“Act”)

ALTHEA GROUP HOLDINGS LIMITED (ASX Code: AGH) ( "Company" ) issued 6,615,859 fully paid ordinary shares in connection with the conversion of the exchangeable shares announced in connection with acquisition of Peak Processing on 25 July 2019.

The Company advises that:

• the shares were issued without disclosure to investors under Part 6D.2 of the Act;

• this notice is being given under section 708A(5)(e) of the Act;

• as at the date of this notice, the Company has complied with:

  • the provisions of Chapter 2M of the Act as they apply to it; and

  • section 674 of the Act; and

• as at the date of this notice, there is no excluded information of the type referred to in subsections 708A(7) and 708A(8) of the Act that is required to be set out in this notice.

-ENDS-

Authorised by: Robert Meissner, Company Secretary

For further information, please contact:

Althea Media Enquiries Investor Relations Josh Fegan Dan Francome Jane Morgan CEO & Managing Director Media Relations Investor Relations Partner M: 1300 70 20 20 P: +613 9650 5096 M: +61 405 555 618 E: contact@althea.life E: dfrancome@althea.life E: jm@janemorganmanagement.com.au

Althea Group Holdings Limited (ASX:AGH)

Althea Group Holdings Ltd (ASX:AGH) is a global pharmaceutical company and supplier of medicinal cannabis. Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.

Althea currently operates within highly regulated medicinal cannabis markets including Australia, United Kingdom and Germany, with plans to expand into emerging markets throughout Asia and Europe.

To learn more, please visit: www.althea.life

==> picture [595 x 92] intentionally omitted <==